Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCURAY INCARAY · Entity 1170 | SVP, Chief Financial Officer | July 03, 2018 | July 07, 2018 |
| PROCEPT BioRobotics CorpPRCT · Entity 4831 | EVP, CFO | September 09, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCURAY INC
Report date July 03, 2018 · Filed July 07, 2018 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 313,619 |
Reported balance
After 2018-07-03 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2018-07-03 · Sale · Disposed 14,641 · Balance 313,619 F1: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
PROCEPT BioRobotics Corp
Report date September 09, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 180,355 |
Reported balance
After 2026-09-09 transaction · row 1
1 source rowRow 1 · 2026-09-09 · Sale · Disposed 373 · Balance 180,355 F1: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 10, 2026 20:42 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 373 | $20.95 | $7,815.47 |
DisclosureSEC source: 0001653771-26-000002 · wk-form4_1789072973.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,355 F1 · kind: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026. Read SEC document |
| August 13, 2026 Filed Aug 14, 2026 20:34 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 40,851 | $0.00 Strike: $21.95 | $0.00 |
DisclosureSEC source: 0001628280-26-057160 · wk-form4_1786739675.xml · derivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,851 Underlying: Common Stock · 40,851 shares Expires 2036-08-12 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of August 13, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant. Read SEC document |
| August 13, 2026 Filed Aug 14, 2026 20:34 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 29,527 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-057160 · wk-form4_1786739675.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,728 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on August 13, 2027, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:18 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 357 | $28.48 | $10,167.00 |
DisclosureSEC source: 0001628280-26-042218 · wk-form4_1781122684.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,201 F1 · shares: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on June 5, 2026. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 20:25 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 706 | $28.15 | $19,876.16 |
DisclosureSEC source: 0001628280-26-019830 · wk-form4_1773951913.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,558 F1 · shares: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 21:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 6,721 | $23.70 | $159,300.47 |
DisclosureSEC source: 0001628280-26-016151 · wk-form4_1773092446.xml · nonDerivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,264 F2 · shares: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units and Performance Stock Units. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 21:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 32,576 | $0.00 Strike: $25.35 | $0.00 |
DisclosureSEC source: 0001628280-26-016151 · wk-form4_1773092446.xml · derivative · entry 3 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,576 Underlying: Common Stock · 32,576 shares Expires 2036-03-04 F3 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 21:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 47,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-016151 · wk-form4_1773092446.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,985 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| February 19, 2026 Filed Feb 25, 2026 21:46 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 3,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011744 · wk-form4_1772056009.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,523 F1 · kind: Represents shares of common stock underlying a portion of an award of performance stock units ("PSUs") previously granted by the Issuer, the vesting of which was subject to the Issuer's achievement of certain pre-determined performance criteria. Upon certification by the Issuer's Compensation Committee on February 19, 2026, of the achievement of such performance criteria, the number of PSUs reported herein was deemed earned, which will vest on March 5, 2026. Each PSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 18, 2025 Filed Mar 19, 2025 20:15 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 733 | $57.06 | $41,824.98 |
DisclosureSEC source: 0001628280-25-013830 · wk-form4_1742415331.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,991 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:28 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 3,662 | $61.31 | $224,517.22 |
DisclosureSEC source: 0001628280-25-011703 · wk-form4_1741638492.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,724 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:32 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 14,388 | $0.00 Strike: $60.60 | $0.00 |
DisclosureSEC source: 0001628280-25-010602 · wk-form4_1741213906.xml · derivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,388 Underlying: Common Stock · 14,388 shares Expires 2035-03-02 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:32 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 16,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010602 · wk-form4_1741213906.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,386 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:27 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $4.56 | $0.00 |
DisclosureSEC source: 0001628280-24-043032 · wk-form4_1729196860.xml · derivative · entry 5 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,160 Underlying: Common Stock · 25,000 shares Expires 2029-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option was granted on December 12, 2019 and vested over a four year period. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:27 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 926 | $73.75 | $68,292.50 |
DisclosureSEC source: 0001628280-24-043032 · wk-form4_1729196860.xml · nonDerivative · entry 4 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,096 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.56 to $73.87. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:27 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 8,115 | $73.02 | $592,557.30 |
DisclosureSEC source: 0001628280-24-043032 · wk-form4_1729196860.xml · nonDerivative · entry 3 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,022 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.56 to $73.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:27 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 15,959 | $72.11 | $1,150,803.49 |
DisclosureSEC source: 0001628280-24-043032 · wk-form4_1729196860.xml · nonDerivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,137 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.56 to $72.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:27 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 25,000 | $4.56 | $114,000.00 |
DisclosureSEC source: 0001628280-24-043032 · wk-form4_1729196860.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 21:59 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,083 | $4.56 Strike: $4.56 | $41,418.48 |
DisclosureSEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · derivative · entry 7 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,160 Underlying: Common Stock · 9,083 shares Expires 2029-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The Stock option was granted on December 12, 2019 and vested over a four year period. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 21:59 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,917 | $4.52 Strike: $4.52 | $71,944.84 |
DisclosureSEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · derivative · entry 6 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,917 shares Expires 2028-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The Stock Option was granted on October 23, 2018 and vested over a four year period. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 21:59 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 400 | $83.35 | $33,340.00 |
DisclosureSEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · nonDerivative · entry 5 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,096 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.34 to $83.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 21:59 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 17,977 | $82.69 | $1,486,518.13 |
DisclosureSEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · nonDerivative · entry 4 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,496 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.30 to $83.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 21:59 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 6,623 | $81.96 | $542,821.08 |
DisclosureSEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · nonDerivative · entry 3 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 114,473 F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.30 to $82.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 21:59 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 9,083 | $4.56 | $41,418.48 |
DisclosureSEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · nonDerivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 21:59 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 15,917 | $4.52 | $71,944.84 |
DisclosureSEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 20:48 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 1,024 | $48.83 | $50,001.92 |
DisclosureSEC source: 0001628280-24-012239 · wk-form4_1710967687.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,149 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 22:05 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,747 | $0.00 Strike: $4.56 | $0.00 |
DisclosureSEC source: 0001628280-24-011738 · wk-form4_1710799509.xml · derivative · entry 4 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,243 Underlying: Common Stock · 17,747 shares Expires 2029-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Stock option was granted on December 12, 2019 and vested over a four year period. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 22:05 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 36,010 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001628280-24-011738 · wk-form4_1710799509.xml · derivative · entry 3 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,917 Underlying: Common Stock · 36,010 shares Expires 2028-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Stock Option was granted on October 23, 2018 and vested over a four year period. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 22:05 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 17,747 | $4.56 | $80,926.32 |
DisclosureSEC source: 0001628280-24-011738 · wk-form4_1710799509.xml · nonDerivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 22:05 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 36,010 | $4.52 | $162,765.20 |
DisclosureSEC source: 0001628280-24-011738 · wk-form4_1710799509.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 00:51 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 16,835 | $0.00 Strike: $47.17 | $0.00 |
DisclosureSEC source: 0001628280-24-009764 · wk-form4_1709859091.xml · derivative · entry 3 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,835 Underlying: Common Stock · 16,835 shares Expires 2034-03-05 F4 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2024 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 00:51 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 3,435 | $46.67 | $160,311.45 |
DisclosureSEC source: 0001628280-24-009764 · wk-form4_1709859091.xml · nonDerivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,416 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on February 16, 2023. F3 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 00:51 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 19,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009764 · wk-form4_1709859091.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,851 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2024, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 06, 2024 Filed Apr 19, 2024 23:06 UTC Amendment | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 11,563 | $0.00 Strike: $47.17 | $0.00 |
DisclosureSEC source: 0001628280-24-017005 · wk-form4a_1713567971.xml · derivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,563 Underlying: Common Stock · 11,563 shares Expires 2034-03-05 F3 · shares: This Form 4 amendment corrects a clerical error in the number of shares underlying the stock option granted to the reporting person on March 6, 2024. F4 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2024 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 06, 2024 Filed Apr 19, 2024 23:06 UTC Amendment | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 13,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-017005 · wk-form4a_1713567971.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,798 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2024, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. F2 · shares: This Form 4 amendment corrects a clerical error in the number of shares of common stock granted in the form of RSUs to the reporting person on March 6, 2024. The incorrect total common stock share amount was also reported in one subsequent transaction on the original Form 4, and one subsequent Form 4 filed by the reporting person after the original Form 4 was filed. Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 21:37 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,349 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001628280-24-004486 · wk-form4_1707860221.xml · derivative · entry 3 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,927 Underlying: Common Stock · 22,349 shares Expires 2028-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Option was granted on October 23, 2018 and vested over a four year period. Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 21:37 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 22,349 | $50.16 | $1,121,061.60 |
DisclosureSEC source: 0001628280-24-004486 · wk-form4_1707860221.xml · nonDerivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,523 F1 · kind: All transactions reported were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 21:37 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 22,349 | $4.52 | $101,017.48 |
DisclosureSEC source: 0001628280-24-004486 · wk-form4_1707860221.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. Read SEC document |
| February 09, 2024 Filed Feb 9, 2024 22:09 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 28,677 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001628280-24-004120 · wk-form4_1707516534.xml · derivative · entry 6 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,276 Underlying: Common Stock · 28,677 shares Expires 2028-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Option was granted on October 23, 2018 and vested over a four year period. Read SEC document |
| February 09, 2024 Filed Feb 9, 2024 22:09 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 28,677 | $50.09 | $1,436,379.31 |
DisclosureSEC source: 0001628280-24-004120 · wk-form4_1707516534.xml · nonDerivative · entry 4 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,523 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 09, 2024 Filed Feb 9, 2024 22:09 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 28,677 | $4.52 | $129,620.04 |
DisclosureSEC source: 0001628280-24-004120 · wk-form4_1707516534.xml · nonDerivative · entry 3 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 22:09 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 904 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001628280-24-004120 · wk-form4_1707516534.xml · derivative · entry 5 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,953 Underlying: Common Stock · 904 shares Expires 2028-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Option was granted on October 23, 2018 and vested over a four year period. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 22:09 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 904 | $50.00 | $45,200.00 |
DisclosureSEC source: 0001628280-24-004120 · wk-form4_1707516534.xml · nonDerivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,523 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 22:09 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 904 | $4.52 | $4,086.08 |
DisclosureSEC source: 0001628280-24-004120 · wk-form4_1707516534.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 22:03 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,310 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001628280-24-001189 · wk-form4_1705010595.xml · derivative · entry 3 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,857 Underlying: Common Stock · 17,310 shares Expires 2028-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. F3 · derivative.exercise_date: The Stock Option was granted on October 23, 2018 and vested over a four year period. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 22:03 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 17,310 | $45.07 | $780,246.52 |
DisclosureSEC source: 0001628280-24-001189 · wk-form4_1705010595.xml · nonDerivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,523 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45 to $45.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 09, 2024 Filed Jan 11, 2024 22:03 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 17,310 | $4.52 | $78,241.20 |
DisclosureSEC source: 0001628280-24-001189 · wk-form4_1705010595.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 23:19 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 71,465 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001628280-23-041701 · wk-form4_1702682335.xml · derivative · entry 3 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,167 Underlying: Common Stock · 71,465 shares Expires 2028-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023 F3 · derivative.exercise_date: The Stock Option was granted on October 23, 2018 and vested over a four year period. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 23:19 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 71,465 | $40.05 | $2,862,216.13 |
DisclosureSEC source: 0001628280-23-041701 · wk-form4_1702682335.xml · nonDerivative · entry 2 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,523 F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 23:19 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 71,465 | $4.52 | $323,021.80 |
DisclosureSEC source: 0001628280-23-041701 · wk-form4_1702682335.xml · nonDerivative · entry 1 Waters Kevin · CIK 0001653771 · EVP, CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.